✦ LIBER ✦

Long-Term Outcome of Fludarabine-Based Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation for Debilitating Paroxysmal Nocturnal Hemoglobinuria

✍ Scribed by Pantin, Jeremy; Tian, Xin; Geller, Nancy; Ramos, Catalina; Cook, Lisa; Cho, Elena; Scheinberg, Phillip; Vasu, Sumithira; Khuu, Hahn; Stroncek, David; Barrett, John; Young, Neal S.; Donohue, Theresa; Childs, Richard W.

Book ID: 124105696
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 731 KB
Volume: 20
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2014.05.012

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

16: Long-Term Results of a Gitmo Retrosp

16: Long-Term Results of a Gitmo Retrospective Study on Hematopoietic Stem Cell Transplantation (HSCT) for Paroxysmal Nocturnal Hemoglobinuria (PNH)

✍ S. Santarone; E. Di Bartolomeo; A. Bacigalupo; E. Tagliaferri; A. Iori; A. Risit 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Long-term follow-up of reduced-intensity

Long-term follow-up of reduced-intensity allogeneic hematopoietic stem cell transplantation for refractory or relapsed follicular lymphoma

✍ Yukako Ono; Takehiko Mori; Jun Kato; Akiko Yamane; Takayuki Shimizu; Taku Kikuch 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 721 KB

Similar Risks for Chronic Kidney Disease

✍ Ahmed Al-Hazzouri; Qing Cao; Linda J. Burns; Daniel J. Weisdorf; Navneet S. Majh 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 227 KB

Moderate Renal Function Impairment Does

Moderate Renal Function Impairment Does Not Affect Outcomes of Reduced-Intensity Conditioning with Fludarabine and Melphalan for Allogeneic Hematopoietic Stem Cell Transplantation

✍ Jonas A. de Souza; Rima M. Saliba; Poliana Patah; Gabriela Rondon; Rachel Ribeir 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 192 KB

Higher Busulfan Dose Intensity Does Not

Higher Busulfan Dose Intensity Does Not Improve Outcomes of Patients Undergoing Allogeneic Hematopoietic Cell Transplantation (AHCT) Following Fludarabine/Busulfan/Atg (FBA)-Based Reduced Toxicity Conditioning (RTC)

✍ M. Hamadani; M. Craig; J. Abraham; W. Tse; A. Cumpston; L.F. Gibson; S.C. Remick 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Long-Term Outcomes of Alemtuzumab-Based

Long-Term Outcomes of Alemtuzumab-Based Reduced-Intensity Conditioned Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndrome and Acute Myelogenous Leukemia Secondary to Myelodysplastic Syndrome

✍ Potter, Victoria T.; Krishnamurthy, Pramila; Barber, Linda D.; Lim, ZiYi; Kenyon 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 595 KB